Pfizer Accused of Knowing Zoloft Posed Birth Risk
This article is for subscribers only.
Pfizer Inc. researchers concluded last year that pregnant women taking Zoloft risked having babies with heart defects, according to evidence made public by a lawyer at the first trial of more than 1,000 lawsuits over the drug.
The May 2014 internal report on the antidepressant found that newborns of women taking the mood-altering drug were at risk of suffering congenital anomalies, according to a portion of the report presented by a lawyer for the mother of a boy born with a heart defect.